Andy Vicari & Anne Peters MD
Andy Vicari is Senior Director & U.S. Brand Leader for the Insulins portfolio at Eli Lilly and Company. In this role, Andy leads the brand teams in developing and executing cross-portfolio marketing strategies across various insulin brands at Lilly. Andy has held several leadership positions in sales and marketing. Outside of work, Andy serves on the Board of Directors for the American Diabetes Association. He earned a bachelor’s degree in Biomedical Sciences from St. Cloud State University and a Master of Business Administration from the University of Illinois at Urbana-Champaign.
Anne L. Peters, MD, is a professor of clinical medicine at the Keck School of Medicine of the University of Southern California and the Director of the USC Clinical Diabetes Programs. She runs diabetes centers in Beverly Hills and in underserved East Los Angeles. In addition to her clinical work, she has been a PI on multiple grants and has written over 200 abstracts and articles and 4 books. Her major interests involve translating research findings, from lifestyle interventions to technology, to people with diabetes throughout the socioeconomic spectrum. She has been part of the writing groups for the ADA guidelines for the treatment of both type 1 and type 2 diabetes, is a member of the EASD/ADA Device Safety committee, Chair of the Endocrine Society Technology Guideline Writing Group, the JDRF Technology Education Initiative and the ADA Technology Interest Group. She is also a member of the ADA Professional Practice Committee. She was presented with the ADA “Outstanding Physician Clinician” award, the Bernardo Alberto Houssay Award from the National Minority Quality Forum and has been listed on the “Best Doctors in America” continuously since 2001